Chemours sells Glycolic Acid Business to PureTech Scientific for $137M
The Chemours Company has entered into a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capital. With this acquisition, PureTech Scientific is positioning itself to become the global leader in organic synthesis of ultra-high purity alpha hydroxy acids … Read more